BCYC - BICYCLE THERAPEUTICS plc

QQQ $ 455.25 $ 5.77 (1.29 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 6.05 (1.12 %)

TLT $ 99.96 $ 0.43 (0.43 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 26.36

Open

Bid

$ 26.31 x 200

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 12.54 - $ 27.24

Volume

874,097

Average Volume

Market Cap

1.82B

Beta (5Y Monthly)

$ 1.05

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Bicycle Therapeu...
09/09/2024 17:23:53

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 12:55:43

Cantor Fitzgerald analyst Li Watsek reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Overweight.

bicycle-therapeutics-lead-cancer-candidates-has-high-opportunity-analyst-initiates-with-bullish-tone

Bicycle Therapeutics' Lead Cancer Candidat...
09/06/2024 17:37:16

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safe...

In-Depth Examination Of 5 Analyst Recommen...
09/06/2024 12:01:06

RBC Capital Initiates Coverage On Bicycle ...
09/06/2024 09:56:24

RBC Capital analyst Gregory Renza initiates coverage on Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform rating and anno...

The Latest Analyst Ratings For Bicycle The...
08/07/2024 21:00:17

HC Wainwright & Co. Reiterates Buy on Bicy...
08/07/2024 20:17:14

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintain...

Oppenheimer Maintains Outperform on Bicycl...
08/07/2024 18:01:08

Oppenheimer analyst Jay Olson maintains Bicycle Therapeutics (NASDAQ:BCYC) with a Outperform and maintains $48 price target.

5Needham Reiterates Buy on Bicycle Therape...
08/07/2024 10:39:02

Needham analyst Ami Fadia reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintains $38 price target.

B. Riley Securities Downgrades Bicycle The...
08/07/2024 09:55:23

B. Riley Securities analyst Kalpit Patel downgrades Bicycle Therapeutics (NASDAQ:BCYC) from Buy to Neutral and lowers the pr...

Bicycle Therapeutics Q2 2024 GAAP EPS $(0....
08/06/2024 12:00:30

Bicycle Therapeutics Filed A Prospectus Su...
06/18/2024 20:23:42

- SEC Filing

dow-dips-over-550-points-bjs-wholesale-club-earnings-beat-views

Dow Dips Over 550 Points; BJ's Wholesale C...
05/23/2024 18:40:33

gold-falls-sharply-us-composite-pmi-surges-in-may

Gold Falls Sharply; US Composite PMI Surge...
05/23/2024 16:01:36

elf-beauty-posts-upbeat-earnings-joins-nvidia-liveramp-holdings-borr-drilling-and-other-big-stocks-moving-higher-on-thursday

e.l.f. Beauty Posts Upbeat Earnings, Joins...
05/23/2024 14:26:28

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
05/23/2024 12:06:48

Bicycle Therapeutics Reports $555M Private...
05/23/2024 11:16:44

The company has entered into a securities purchase agreement with certain existing and new accredited investors to issue and se...

HC Wainwright & Co. Reiterates Buy on Bicy...
05/03/2024 19:20:12

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Bicycle Therapeutics (NASDAQ:BCYC) with a Buy and maintain...

Bicycle Therapeutics' Cash And Cash Equiva...
05/02/2024 11:53:41

Bicycle Therapeutics Q1 2024 GAAP EPS $(0....
05/02/2024 11:53:23

Bicycle Therapeutics (NASDAQ:BCYC) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of ...